medmix AG
SIX:MEDX.SW
9.62 (CHF) • At close November 8, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) CHF.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|
| Assets: | ||||||
| Current Assets: | ||||||
| Cash & Cash Equivalents
| 130.6 | 313.5 | 209.8 | 14.8 | 4.5 | 16.2 |
| Short Term Investments
| -22.4 | 3.3 | 0.2 | 31.4 | 74.8 | 67.7 |
| Cash and Short Term Investments
| 130.6 | 316.8 | 210 | 46.2 | 79.3 | 83.9 |
| Net Receivables
| 82.8 | 68.8 | 50.6 | 45.1 | 45.2 | 67.5 |
| Inventory
| 88.4 | 91.8 | 79.2 | 63 | 62.2 | 63.7 |
| Other Current Assets
| 6.3 | 7.6 | -0.1 | 0.2 | -0.1 | -0.1 |
| Total Current Assets
| 308.1 | 489 | 339.7 | 154.5 | 186.6 | 215 |
| Non-Current Assets: | ||||||
| Property, Plant & Equipment, Net
| 258.1 | 229.8 | 229.8 | 207.3 | 151.6 | 117.7 |
| Goodwill
| 268.5 | 254.4 | 258 | 263.2 | 217.4 | 221.5 |
| Intangible Assets
| 127.5 | 120.5 | 135.9 | 158.7 | 137.1 | 159.7 |
| Goodwill and Intangible Assets
| 396 | 374.9 | 393.9 | 421.9 | 354.5 | 381.2 |
| Long Term Investments
| 35.8 | 3.2 | -0.1 | 0 | 0 | 0.3 |
| Tax Assets
| 8.7 | 5.8 | 4.2 | 6.2 | 4.1 | 3.8 |
| Other Non-Current Assets
| 0.1 | 3.3 | 6.9 | -0.1 | 0.1 | 0.1 |
| Total Non-Current Assets
| 698.7 | 617 | 634.7 | 635.3 | 510.3 | 503.1 |
| Total Assets
| 1,006.8 | 1,105.9 | 974.4 | 789.9 | 697 | 718.1 |
| Liabilities & Equity: | ||||||
| Current Liabilities: | ||||||
| Account Payables
| 49.4 | 47.4 | 41.1 | 29.8 | 37.8 | 42 |
| Short Term Debt
| 42.2 | 164.1 | 24.2 | 52.9 | 17.4 | 10.2 |
| Tax Payables
| 14.6 | 6.3 | 10 | 6.1 | 6.9 | 10.8 |
| Deferred Revenue
| 84.1 | 58.1 | 50.1 | 48.2 | 49.4 | 38.8 |
| Other Current Liabilities
| 2.4 | 1.5 | 2 | 3.5 | 1.2 | 1.7 |
| Total Current Liabilities
| 178.1 | 271.1 | 117.4 | 134.4 | 105.8 | 92.7 |
| Non-Current Liabilities: | ||||||
| Long Term Debt
| 307.5 | 309.4 | 296.7 | 279.4 | 259.2 | 249.9 |
| Deferred Revenue Non-Current
| 16.1 | 4.6 | 6.7 | 14.9 | 12 | 5.3 |
| Deferred Tax Liabilities Non-Current
| 19.4 | 16.1 | 19.6 | 26.7 | 23.9 | 29.2 |
| Other Non-Current Liabilities
| 11.3 | -0.1 | 0.1 | 1.1 | 1 | 1.3 |
| Total Non-Current Liabilities
| 354.3 | 330 | 323.1 | 322.1 | 296.1 | 285.7 |
| Total Liabilities
| 532.4 | 601.1 | 440.5 | 456.5 | 401.9 | 378.4 |
| Equity: | ||||||
| Preferred Stock
| 49.6 | 0 | 0 | 0 | 0 | 0 |
| Common Stock
| 0.4 | 0.4 | 0.4 | 333.4 | 295.1 | 339.7 |
| Retained Earnings
| 529.8 | 540.3 | 552.8 | 345.7 | 303.7 | 338.6 |
| Accumulated Other Comprehensive Income/Loss
| -49.6 | -23.4 | -12.8 | -12.3 | -8.6 | 1.1 |
| Other Total Stockholders Equity
| -64.8 | -12.5 | -6.5 | -333.4 | -295.1 | -339.7 |
| Total Shareholders Equity
| 465.4 | 504.8 | 533.9 | 333.4 | 295.1 | 339.7 |
| Total Equity
| 474.4 | 504.8 | 533.9 | 333.4 | 295.1 | 339.7 |
| Total Liabilities & Shareholders Equity
| 1,006.8 | 1,105.9 | 974.4 | 789.9 | 697 | 718.1 |